Noelle Sunstrom

Founder and CEO at NeuClone
  • Claim this Profile
Contact Information
Location
New South Wales, Australia, AU

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Australia
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Founder and CEO
      • Feb 2007 - Present

      Founder, CEO.

    • Australia
    • Biotechnology Research
    • 1 - 100 Employee
    • Co-founder/Scientific Director
      • Dec 2001 - Feb 2007

      As Scientific Director Dr Sunstrom developed gene expression systems for the production of biopharmaceutical products in CHO cells. As Executive Director she was involved in setting strategic direction, developing research initiatives and practices; writing company documents including investment & business plans.

    • Australia
    • Higher Education
    • 700 & Above Employee
    • Associate Professor (Adjunct)
      • Jan 2000 - Jan 2007

      School of Biotechnology and Molecular Sciences

    • Deputy Director
      • Jan 1999 - Jun 2001

      Supervision of University-operated facility for recombinant-protein production; Dr Sunstrom was member of the steering committee for the GMP production of a lead therapeutic monoclonal antibody used in clinical trials involving colon cancer patients in collaboration with the Garvan Institute and St Vincent’s Hospital; project managed the commercial production of proteins using mammalian and bacterial expression systems.

    • Deputy Director
      • Jan 1998 - Jun 2000

      Research undertaken by the Cooperative Research Centre (CRC) for Biopharmaceutical Research included areas such as genetic engineering, biotechnology, physiology., pharmacology, clinical trial, molecular modelling, structural analysis and drug development. Responsibilities included recruitment of scientific staff to individual projects/contracts; Project management of internal alliances for protein production and early stage cell line development;

Education

  • Harvard Business School
    Disruptive Innovation
    2017 - 2017
  • Australian Graduate School of Management
    MBA (Executive)
    2005 - 2007
  • The Australian National University
    Post-doctoral Research Fellow, Influenza Research
    1992 - 1994
  • McGill University
    PhD, Dept of Micribiology & Immunology; Molecular Virology
    1986 - 1991

Community

You need to have a working account to view this content. Click here to join now